Present invention relates to water dispersible pharmaceutical formulations comprising cefdinir and clavulanic acid and/or pharmaceutically acceptable salts, hydrates, enantiomers, racemates, organic salts, inorganic salts, esters, polymorphs, crystal forms and amorphous forms and/or combinations thereof suitable for oral use and for use in treatment of infectious diseases caused by resistant bacteria.